Back to LCTX
NORGES BANK LCTX Position History
Lineage Cell Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$601.9M
Q2 2026
Peak value
$668.6M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $668.6M |
| Q3 2025 | $532.4M |
| Q4 2025 | $482.3M |
| Q2 2026 | $601.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $601.9M | 13.92M | — | — |
| Q4 2025 | $482.3M | 13.78M | — | — |
| Q3 2025 | $532.4M | 13.78M | — | — |
| Q1 2025 | $668.6M | 11.40M | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M